Followers | 37 |
Posts | 2134 |
Boards Moderated | 0 |
Alias Born | 12/20/2010 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, June 17, 2013 4:19:50 PM
foggdogg
Sunday, June 16, 2013 8:34:39 PM
Re: rubs1 post# 3351
Post # of 3358
I dont think so...the way I understood it was that BVI would contain all the current trials that are underway and that Stromacel would keep all the IP concerning the heart, diabetes, and the skin cream. But dont quote me....lol
Fogg that's the way I understand it as well. The licenses are transferred to the BVI company and Shareholders of record are compensated for this "loss" by gaining 1 share of the BVI for each share they had of PROT.
The StromCel side has a lot of potential! Heart, Diabetes, Proteoderm. IMVHO we're not losing, we're gaining.
Your life is trite and jaded,
Boring and confiscated.
If that's your best, your best won't do.
FEATURED Mawson Finland Provides Update on Exploration Activities at Rajapalot • Aug 21, 2024 9:06 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM